| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Septerna, Inc. | 10%+ Owner | Common Stock | 6,215,591 | $37,287,330 | $6.00 | 24 Feb 2025 | Indirect |
| Septerna, Inc. | 10%+ Owner | Common Stock | 4,211,659 | $25,265,742 | $6.00 | 24 Feb 2025 | Direct |
| Tango Therapeutics, Inc. | Director | Common Stock | 194,174 | $1,629,392 | $8.39 | 11 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SEPN | Septerna, Inc. | 24 Feb 2025 | 1 | +$113,147 | 4 | 10%+ Owner | 26 Feb 2025, 16:15 |
| SEPN | Septerna, Inc. | 20 Feb 2025 | 2 | +$6,167,378 | 4 | 10%+ Owner | 24 Feb 2025, 16:15 |
| TNGX | Tango Therapeutics, Inc. | 11 Aug 2023 | 0 | $0 | 3 | Director | 22 Aug 2023, 16:15 |